Ads
    Related paper
  1. CHANGES RANGE OF FATTY ACID PLATELETS PHOSPHOLIPID MEMBRANES IN CORONARY HEART DISEASE COMBINED WITH PAROXYSMAL ATRIAL FIBRILLATION PATIENTS
  2. Estimation of lipid peroxidation and neurovegetative homeostasis at patients with ischemic heart disease with paroxysmal atrial fibrillation
  3. Left Ventricular Myocardial Remodeling among Patients with Ischemic Heart Disease Combined with Hypertension and Persistent Atrial Fibrillation
  4. Correction of Dyslipidemia in Patients with Coronary Heart Disease Combined with Nonalcoholic Fatty Liver Disease
  5. The Effectiveness of the Influence of Median-Dose StatinTherapy on the Serum Lipid Profilein Patients with Stable Coronary Heart Disease, Combined with Non-Alcoholic Fatty Liver Disease at the Stage of Steatosis
  6. Different Role of Left Atrial Size and Function in Patients with Paroxysmal versus Persistent Atrial Fibrillation. Wellnhofer: LA Size & Function in Atrial Fibrillation
  7. Clinical course and risk prediction of permanent atrial fibrillation development in patients with chronic heart failure and mid-range ejection fraction of the left ventricle
  8. ANALYSIS OF MANAGEMENT TACTICS IN PATIENTS WITH CORONARY ARTERY DISEASE AND ATRIAL FIBRILLATION IN REAL OUTPATIENT PRACTICES
  9. Features of the arterial hypertension clinical course in patients with ischemic heart disease and atrial fibrillation
  10. Assessment of Copper Status in Patients with Paroxysmal Atrial Fibrillation